SURVEY METHOD FOR POST-MARKETING DRUG SURVEILLANCE - A DEMONSTRATION

被引：0
|
作者：
MELLINGER, GD
BALTER, MB
ABRAMOWITZ, S
SCHAFFER, CB
BERNSTEIN, LR
机构：
[1] TUFTS UNIV,SCH MED,DEPT PSYCHIAT,BOSTON,MA 02111
[2] JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT MENTAL HYG,BALTIMORE,MD 21218
[3] INST RES SOCIAL BEHAV,OAKLAND,CA
[4] NIMH,ROCKVILLE,MD 20857
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 1988年 / 8卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：168 / 176
页数：9
相关论文
共 50 条
  • [31] POST-MARKETING SURVEILLANCE OF OFLOXACIN IN JAPAN
    YAMADA, A
    NAKAMURA, S
    TAKAHASHI, K
    SAWADA, M
    OKADA, S
    REVIEWS OF INFECTIOUS DISEASES, 1989, 11 : S1409 - S1409
  • [32] Post-Marketing Surveillance of Prescription Drug Safety: Past, Present, and Future
    Chen, Brian K.
    Yang, Y. Tony
    JOURNAL OF LEGAL MEDICINE, 2013, 34 (02) : 193 - 213
  • [33] An Information Technology Architecture for Drug Effectiveness Reporting and Post-Marketing Surveillance
    Gupta, Amar
    Woosley, Ray
    Crk, Igor
    Sarnikar, Surendra
    INTERNATIONAL JOURNAL OF HEALTHCARE INFORMATION SYSTEMS AND INFORMATICS, 2007, 2 (03) : 65 - 80
  • [34] Hemangiol in infantile haemangioma: A paediatric post-marketing surveillance drug study
    Socchi, Floriane
    Bigorre, Michele
    Normandin, Marion
    Captier, Guillaume
    Bessis, Didier
    Mondain, Michel
    Blanchet, Catherine
    Akkari, Mohamed
    Amedro, Pascal
    Gavotto, Arthur
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (04) : 1970 - 1980
  • [35] Post-marketing surveillance of escitalopram in depressed outpatients
    Möller, HJ
    Lotze, K
    Lange, S
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S428 - S428
  • [36] Challenges and perspectives in surveillance of post-marketing/use
    Fontenele Martins, Mary Anne
    Coelho Penna Teixeira, Ana Paula
    VIGILANCIA SANITARIA EM DEBATE-SOCIEDADE CIENCIA & TECNOLOGIA, 2019, 7 (04): : 3 - 9
  • [37] Distributed, collaborative intelligent agents for proactive post-marketing drug safety surveillance
    Ji, Yanqing
    Ying, Hao
    Farber, Margo S.
    Yen, John
    Dews, Peter
    Miller, Richard E.
    Massanari, R. Michael
    NAFIPS 2007 - 2007 ANNUAL MEETING OF THE NORTH AMERICAN FUZZY INFORMATION PROCESSING SOCIETY, 2007, : 158 - +
  • [38] INFORMATION-SYSTEM FOR POST-MARKETING DRUG SURVEILLANCE SCHEME ON SMALL COMPUTERS
    MOUSSA, MAA
    METHODS OF INFORMATION IN MEDICINE, 1982, 21 (04) : 181 - 186
  • [39] Utility of electronic health records to support post-marketing drug safety surveillance
    Lin, Nancy D.
    Calderbank, Jenna
    Anderson, David
    Seeger, John
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 415 - 415
  • [40] Drug-induced Neuropsychiatric Adverse Events Using Post-Marketing Surveillance
    Wakabayashi, Tomohito
    Nakatsuji, Takahiro
    Kambara, Hiroko
    Niinomi, Iku
    Oyama, Saki
    Inada, Ayaka
    Ueno, Sayaka
    Uchida, Mayako
    Iwanaga, Kazunori
    Iida, Tatsuya
    Hosohata, Keiko
    CURRENT REVIEWS IN CLINICAL AND EXPERIMENTAL PHARMACOLOGY, 2022, 17 (02) : 144 - 148
12345